Leukemia Genomics


Personalized Genomic Testing in Pediatric Oncology


Coffee Break


LKB1/STK11 Axis in Precision Immunotherapy


Targeting Novel Mechanisms


Structural Basis for the Action of Clinical MEK Inhibitors at KSR-Bound MEK


Non-Cell Autonomous Tumor Control via Senescence


Short Talk: Eganelisib (IPI-549) Activity as a Macrophage Reprogramming Therapeutic Candidate in 1L Metastatic TNBC, 2L Metastatic Urothelial Cancer and Other Solid Tumors


Short Talk: SCD1-Regulated Ferroptosis as a Novel Therapeutic Strategy in Non-Small Cell Lung Cancer


Live Poster Session